Skip to content
10-Q

Quarterly Report

ENTEROLOGICS, INC.

0001477932-12-003054

← back to feed
Filed
Aug 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 8, 2012 111 sh
Capex Q2 2012 · Jun 30, 2012 $300K
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$363.93K
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$73.01K
Stockholders Equity Q2 2012 · Jun 30, 2012 $238.76K
Current Liabilities Q2 2012 · Jun 30, 2012 $275K
Current Liabilities Q2 2012 · Dec 31, 2011 $166.2K
Total Liabilities Q2 2012 · Jun 30, 2012 $341.67K
Total Liabilities Q2 2012 · Dec 31, 2011 $232.86K
Current Assets Q2 2012 · Jun 30, 2012 $6.06K
Current Assets Q2 2012 · Dec 31, 2011 $17.98K
Total Assets Q2 2012 · Jun 30, 2012 $580.43K
Total Assets Q2 2012 · Dec 31, 2011 $595.33K
Sga Expense Q2 2012 · Jun 30, 2012 $76.75K
Sga Expense Q2 2012 · Jun 30, 2011 $12.1K
Sga Expense Q2 2012 · Jun 30, 2011 $17.05K
Rd Expense Q2 2012 · Jun 30, 2012 $149.17K
Rd Expense Q2 2012 · Jun 30, 2011 $12.91K
Rd Expense Q2 2012 · Jun 30, 2011 $12.91K
Net Income Q2 2012 · Jun 30, 2012 −$534.93K
Net Income Q2 2012 · Jun 30, 2011 −$48.52K
Net Income Q2 2012 · Jun 30, 2011 −$85.64K
Cost Of Revenue Q2 2012 · Dec 31, 2011 −$243.54K